Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
Screening for ovarian cancer (OC) in women at high risk consists of a combination of carbohydrate antigen 125 (CA125) and transvaginal ultrasound, despite their low sensitivity and specificity. This could be improved by the combination of several biomarkers, which has been shown in average risk pati...
Main Authors: | Daphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, Robert Zeillinger, Dietmar Pils, Daniela Muhr, Elena I Braicu, Marie-Therese Kastner, Yen Y Tan, Lorenz Semmler, Jalid Sehouli, Christian F Singer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5731824?pdf=render |
Similar Items
-
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2018-01-01) -
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients
by: Christian F. Singer, et al.
Published: (2019-04-01) -
Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer
by: Sabine Danzinger, et al.
Published: (2019-07-01) -
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
by: Christina Fotopoulou, et al.
Published: (2012-01-01) -
Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
by: Martin Svoboda, et al.
Published: (2018-08-01)